Stocks
Disc Medicine, Inc.IRON
NASDAQHealthcareBiotechnology$74.51
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for hematologic diseases, with a lead candidate targeting erythropoiesis for conditions like anemia. Investors track it for its pipeline progress and potential in the rare blood disorder market.
52W Range: $40.00-$99.50
Congressional Interest in Disc Medicine, Inc. (IRON)
No congressional trades have been disclosed for Disc Medicine, Inc. (IRON) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IRON?
No congressional trades found for this stock.